Merck & Co Inc
Change company Symbol lookup
Select an option...
MRK Merck & Co Inc
DQ Daqo New Energy Corp
ITRI Itron Inc
PSA-I Public Storage
HSKA Heska Corp
SLGN Silgan Holdings Inc
DYNA Dynastar Holdings Inc
ELMWQ Electric Last Mile Solutions Equity Warrant Exp 24 Aug 2027 *W EXP 08/24/2027
AEHA Aesther Healthcare Acquisition Corp
SSSS SuRo Capital Corp
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Closing Price
$86.12
Day's Change
-0.52 (-0.60%)
Bid
--
Ask
--
B/A Size
--
Day's High
87.62
Day's Low
86.10
Volume
(Average)
Volume:
9,035,613

10-day average volume:
8,538,510
9,035,613

Company Profile

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Valuation Ratios

Price/Earnings (TTM)
13.14x
Price/Sales (TTM)
3.82x
Price/Book (MRQ)
5.05x
Price/Cash Flow (TTM)
10.75x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

September 2022
Current Month
19.4M
Previous Month
19.3M
Percent of Float
0.77%
Days to Cover
2.5621 Days

Share Information

MRK is in a share class of common stock
Float
2.5B
Shares Outstanding
2.5B
Institutions Holding Shares
3,761
73.31%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Kenneth C. FrazierChmn.
  • Robert M. DavisPres.
  • Dean Y. LiPres.
  • Caroline LitchfieldCFO
  • Steven C. Mizell

Address

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.